RE: RNS11 Feb 2021 12:12
@Computer
I agree it was a simplistic view... but in theory it could play out.
I think the vast majority of the LFT capacity to date, as it has expanded over recent months, has been for ABC-19.
I'm sure I saw a Walbrook email to an investor that stated ODX had been stockpiling, as Abingdon have been.
The absence of any mention of that in today's update is telling, to me at least, that next week we will hear more.
What we hear, I'm guessing, will be that we've sold to other parties and not the UK Gov.
The UK Gov demand for that test will come later in the year (4,5,6 months from now?) when this first round of vaccines come up for assessment of effectiveness.
With regards to switching lines for production, Colin has implied it can be done fairly easily.. though I'm sure there are complexities, and a certain amount of time needed, to do it.
With regards to the other Covid test:
Visitect AB, in particular, I think that has a strong future but we just haven't had the capacity to produce at scale to date.
More waiting to find out. Some will say more jam tomorrow... but it's getting more tasty with every passing update.